Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-21-009130

Chief Development Officer sold 4,546 shares at an average $116.33 ($528,857)

From the SEC's structured data for this filing

Trades in this filing

Bozigian Haig P. · Chief Development Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-05 Sale : show line 1 in the form −704 $113.79 $80,109 153,328 D
2021-02-08 Sale : show line 2 in the form −824 $116.85 $96,286 154,934 D
2021-02-08 Sale : show line 3 in the form −1,395 $116.78 $162,912 156,189 D
2021-02-08 Sale : show line 4 in the form −1,623 $116.79 $189,550 157,651 D
Open-market sales · 4,546 sh · avg $116.33 · $528,857

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-08 Grant or award : show line 5 in the form Stock Option +3,188 3,188 D
2021-02-08 Grant or award : show line 6 in the form Restricted Stock Unit +532 532 D
Loading xslF345X03/doc4.xml…